C
Catalyst Pharmaceuticals
CPRX
16.925
USD
-0.315
(-1.83%)
مغلق
حجم التداول
29,432
الربح لكل سهم
0
العائد الربحي
0
P/E
38
حجم السوق
2,545,855,391
الأخبار
العنوان: Catalyst Pharmaceuticals
القطاع: Healthcare
الصناعة: Biotechnology
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.